Roderick Tung

So very proud of what WE are building in the 5th largest city in the US. This is the Banner – University Medicine Phoenix Heart Institute. youtu.be/bhGVyxU7BVQ?si…

Propagation Maps During VT-1 and VT-2.

Revisiting the Link Between Substrate and Ventricular Tachycardia Rate: The Critical Role of Conduction Isthmus Structure and Function @guichard_jb @ivroca

Ventricular tachycardia ablation in ischaemic cardiomyopathy: who, when and how? bit.ly/43S6Zl5

Beautifully done! Other side of the bed=>Empathy. 💞

Thrilled to share our @CircAHA paper explaining how #tirzepatide increases heart rate by speeding up the #pacemaker via GLP-1/GIP receptors, boosting cAMP, and calcium cycling. #iPSC @lulurr2016 @StanfordCVI @StanfordDeptMed @GreenstoneBio @Stanford_ChEMH pubmed.ncbi.nlm.nih.gov/42330097/

"An atrioventricular re-entrant tachycardia (AVRT) ablation procedure was complicated by complete heart block." And the result of patient's suicide attempt. jacc.org/doi/10.1016/j.…

Welcoming @KaranSud3 to the Valley this Fall as he joins our Heart Institute IC/Structural Heart Faculty. He brings a unique skillset to our team with level III advanced imaging in CT/MRI at Mount Sinai and Structural Heart & Electrosurgical training at Emory. Phoenix Rising! @psorajja @DrAnnChiang @RizikMd @AnkurGuptaMD @AnumAsifBukhari

Nice 10 commandments from @DrBradleyKnight. Would only add 11. Postprocedural recap/review: The time you sit in front of the recording system reviewing every maneuver and critical EGM will determine good vs great.

*⃣Comparison of 30-Day Readmission and Same-Day Discharge Rates in Patients Undergoing Pulsed Field vs Radiofrequency Ablation for Atrial Fibrillation: A Multicenter Analysis @hrs_journal July 2026 @HRSonline #EPeeps @NileshMathuria ⭐️Methods: • Prospective multicenter registry from 7 high-volume AF ablation centers. • 697 consecutive pts undergoing first or redo AF ablation in 2024 (352 PFA, 345 RFA). • Additional lesion sets (PWI, CTI, linear lesions) were performed at operator discretion. ➡️Primary endpoint: 30-day hospital readmission. ➡️Secondary endpoints: same-day discharge (SDD), cardiac/procedure-related readmissions, and predictors of readmission and SDD. ⭐️Key findings: ➡️30-day readmission - ⬇️with PFA (4.5% vs. 11.0%) (P=0.002). ➡️Same-day discharge -⬆️ with PFA (80.4% vs. 57.7%) (P<0.001). ➡️Cardiac/procedure-related readmissions - ⬇️ with PFA (3.1% vs 8.4%, P=0.0046). ➡️Similar complication rates - 4.5% vs 5.5%. ✴️On multivariable analysis, RFA independently predicted 30-day readmission (adjusted HR 2.22) and cardiac-related readmission (adjusted HR 2.41). • Readmissions for early AF recurrence were markedly lower after PFA (2 vs 14 patients). *⃣Conclusions: ➡️PFA was associated with fewer 30-day readmissions, greater utilization of same-day discharge, and fewer cardiac/procedure-related readmissions. 🧑‍🎓Clinical perspective: ➡️This study extends the advantages of PFA beyond procedural efficiency and acute safety by demonstrating a meaningful reduction in early healthcare utilization. ➡️The lower readmission rate may reflect several factors— ⬇️post-ablation inflammation, ⬇️early atrial arrhythmia recurrences, shorter procedures, and evolving operator practice patterns. heartrhythmjournal.com/article/S1547-…

NEW Global EP episode: #HRStv host @jczerpa is joined by @EladAnter to revisit the foundational physiology behind atrial fibrillation. While tools for pulmonary vein isolation continue to improve, outcomes have plateaued, so what's actually missing? Dr. Anter offers insights from human electrophysiology research to help explain what triggers AFib and where the field may need to refocus its attention. See the full interview here #EPeeps ➡️ bit.ly/4akPc9K 🎧 Prefer to listen? Tune in to the HRStv Pod on: Apple Podcasts ➡️ apple.co/4qafvFM Spotify ➡️ bit.ly/4n9aQ4u iHeartRadio ➡️ ihr.fm/4naIW82 Audible ➡️ adbl.co/43mNykh Deezer ➡️ bit.ly/47neKBX

@doctorwes @EndeavorHlth Congrats @doctorwes!

42 yrs of medicine, the last 25 at @EndeavorHlth. The last scrub, the last pacer, the last ablations, the fantastic team, wonderful pts. Lucky indeed. Will miss it.

🤯🤯🤯

Great to be back in China 🇨🇳 It’s real, I’ve seen it with my own eyes. The robots are here. #CHRS2026

The evidence has never been stronger to support AF ablation as the most effective first-line therapy for AF

@pnatarajanmd @Amgen Congrats!

I'm very excited to share that I will be joining @Amgen, overseeing cardiometabolic research and human genetics, starting Aug 3! I am excited to shape target identification, biology, and drug discovery as the therapeutic area head for cardiovascular disease, obesity, and general medicine. And I will lead the human genetics efforts, spanning Amgen deCODE genetics (a subsidiary of Amgen), that drive target discovery and biology across all therapeutic areas. I have been incredibly fortunate to interface with truly remarkable individuals and culture across @MassGenBrigham, @broadinstitute, and @harvardmed, where I could not have asked for a more meaningful and enjoyable academic career. Being able to build on my prior work, discover and clarify therapeutic hypotheses, and now carry them through to medicines that reach millions is an opportunity I'm grateful for. I'm very excited for what comes next.